Skip to main content
. 2019 May 24;21(6):838–850. doi: 10.1111/jch.13561

Table 2.

Characteristics of PLWH with hypertension compared with those without hypertension

Characteristics

PLWH with hypertension

N = 139

PLWH without hypertension

N = 312

Total

N = 451

P‐value
Age, mean ± SD 48.1 ± 8.5 42.8 ± 8.4 44.5 ± 8.8 <0.0001
Female, n (%) 109 (78.4) 258 (82.7) 367 (81.4) 0.28
Location of residence
Urban 101 (72.7) 221 (71.1) 322 (71.6) 0.52
Semi‐urban 8 (5.8) 12 (3.9) 20 (4.4)
Rural 30 (21.5) 78 (25.0) 108 (24.0)
Educational level
None 41 (29.5) 82 (26.5) 123 (27.4) 0.13
Primary 56 (40.3) 102 (32.9) 158 (35.2)
Secondary 37 (26.6) 102 (32.9) 139 (31.0)
Tertiary 5 (3.6) 24 (7.7) 29 (6.5)
Marital status
Never married 11 (7.9) 34 (11.0) 45 (10.0) 0.04
Married 60 (43.2) 167 (53.9) 227 (50.6)
Divorced/separated 37 (26.6) 54 (17.4) 91 (20.3)
Widow 31 (22.3) 55 (17.7) 86 (19.2)
Monthly income
>1000 GHs 22 (16.3) 50 (16.2) 75 (16.8) 0.62
500‐1000 GHs 42 (31.1) 97 (31.4) 139 (31.1)
100‐499 51 (37.8) 100 (32.4) 151 (33.8)
<100 7 (5.2) 27 (8.7) 34 (7.6)
Don't know 13 (9.6) 35 (11.3) 48 (10.7)
Smoking
No smoking 131 (94.2) 288 (92.3) 419 (92.9) 0.39
Previous smoking 8 (5.8) 20 (6.4) 28 (6.2)
Current smoking 0 (0.0) 4 (1.3) 4 (0.9)
Current alcohol use 11 (7.9) 26 (8.3) 37 (8.2) 0.88
Fruit intake
0 serving/d 8 (5.8) 15 (4.8) 23 (5.1) 0.71
1‐3 servings/d 56 (40.9) 139 (44.8) 195 (43.6)
4‐7 servings/d 73 (53.3) 156 (50.3) 229 (51.2)
Vegetable intake
0‐1 servings 41 (29.9) 86 (27.7) 127 (28.4) 0.89
2 servings 59 (43.1) 138 (44.5) 197 (44.1)
≥3 servings 37 (27.0) 86 (27.7) 123 (27.5)
Salt at table
Never 91 (66.4) 218 (70.3) 309 (69.1) 0.41
Occasional 12 (8.8) 16 (5.2) 28 (6.3)
Sometimes 23 (16.8) 45 (14.5) 68 (15.2)
Always 11 (8.0) 31 (10.0) 42 (9.4)
Physical activity, n (%) 44 (31.7) 96 (30.8) 140 (31.0) 0.85
cART use
Yes 92 (66.2) 158 (50.6) 250 (55.4) 0.002
No 47 (33.8) 154 (49.4) 201 (44.6)
Duration of HIV diagnosis, mean ± SD 6.4 ± 5.6 4.7 ± 4.9 5.2 ± 5.2 0.002
CD4 count, nadir 302.7 ± 261.0 261.9 ± 239.1 274.4 ± 246.5 0.11
CD4 count, current 534.8 ± 336.6 484.5 ± 350.2 499.8 ± 346.5 0.16
Clinical stage at diagnosis
1 40 (29.6) 87 (28.6) 127 (28.9) 0.57
2 34 (25.2) 72 (23.7) 106 (24.1)
3 49 (36.3) 127 (41.8) 176 (40.1)
4 12 (8.9) 18 (5.9) 30 (6.8)
Total cholesterol, mean ± SD 4.8 ± 1.3 5.3 ± 1.4 5.1 ± 1.4 0.0003
LDL cholesterol, mean ± SD 3.05 ± 1.07 3.20 ± 1.04 3.16 ± 1.05 0.16
HDL cholesterol, mean ± SD 1.32 ± 0.48 1.34 ± 0.50 1.34 ± 0.49 0.59
Triglyceride, mean ± SD 1.34 ± 1.07 1.51 ± 1.04 1.46 ± 1.05 0.10
Dyslipidemia, n (%) 113 (81.3) 252 (80.8) 365 (80.9) 0.90
Raised total cholesterol, n (%) 55 (39.6) 165 (52.9) 220 (48.8) 0.009
Raised LDL cholesterol, n (%) 52 (37.4) 133 (42.6) 185 (41.0) 0.30
Low HDL cholesterol, n (%) 45 (32.4) 82 (26.3) 127 (28.2) 0.18
Raised triglyceride, n (%) 24 (17.3) 95 (30.5) 119 (26.4) 0.003
Body mass index, mean ± SD 27.6 ± 5.3 25.2 ± 5.4 25.9 ± 5.5 <0.0001
BMI cutoff
<18.5 kg/m2 2 (1.4) 21 (6.8) 23 (5.1) 0.0002
18.5‐24.9 kg/m2 48 (34.8) 150 (48.4) 198 (44.2)
25.0‐29.9 kg/m2 43 (31.2) 84 (27.1) 127 (28.3)
>30.0 kg/m2 45 (32.6) 55 (17.7) 100 (22.3)
Waist‐to‐hip ratio, mean ± SD 0.90 ± 0.07 0.87 ± 0.08 0.88 ± 0.08 0.0009
Raised WHR 98 (70.5) 190 (60.9) 288 (63.9) 0.05
eGFR, mean ± SD 85.7 ± 9.0 84.2 ± 11.7 84.7 ± 11.0 0.18